N-hydroxyguanidine compound 1-(3,4-dimethoxy-2-chlorobenzylideneamino)- 3-hydroxyguanidine inhibits the xanthine oxidase mediated generation of superoxide radical

Archives of Biochemistry and Biophysics

Volumn 377, Issue 1, 2000, Pages 101-108

  Dambrova, Maija ^a,b   Baumane, Larisa ^b   Kiuru, Anne ^a   Kalvinsh, Ivars ^b   Wikberg, Jarl E S ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

Allopurinol; EPR; Inhibitor; N hydroxyguanidine derivative; Superoxide; Xanthine oxidase

Indexed keywords

1 (3,4 DIMETHOXY 2 CHLOROBENZYLIDENEAMINO) 3 HYDROXYGUANIDINE; 1 (3,4 DIMETHOXY 2 CHLOROBENZYLIDENEAMINO)GUANIDINE; ALLOPURINOL; GUANIDINE DERIVATIVE; SUPEROXIDE; UNCLASSIFIED DRUG; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ARTICLE; CATALYSIS; DRUG SYNTHESIS; ELECTRON SPIN RESONANCE; ENZYME INHIBITION; ENZYME KINETICS; HEART MUSCLE ISCHEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OXIDATION; PRIORITY JOURNAL; PURINE METABOLISM; REPERFUSION INJURY;

EID: 0034192246     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.2000.1745     Document Type: Article

References (25)

1. Kooij A. Histochem. J. 26:1994;889-915.
2. Parks D. A., Granger D. N. Acta Physiol. Scand. Suppl. 548:1986;87-99.
3. Hille R., Nishino T. FASEB J. 9:1995;995-1003.
4. Amaya Y., Yamazaki K., Sato M., Noda K., Nishino T., Nishino T. J. Biol. Chem. 265:1990;14170-14175.
5. Poss W. B., Huecksteadt T. P., Panus P. C., Freeman B. A., Hoidal J. R. Am. J. Physiol. 270:1996;L941-L946.
6. McCord J. M. N. Engl. J. Med. 312:1985;159-163.
7. Nishino T., Nakanishi S., Okamoto K., Mizushima J., Hori H., Iwasaki T., Nishino T., Ichimori K., Nakazawa H. Biochem. Soc. Trans. 25:1997;783-786.
8. Xia Y., Khatchikian G., Zweier J. L. J. Biol. Chem. 271:1996;10096-10102.
9. Saugstad O. D. Pediatrics. 98:1996;103-107.
10. Salaris S. C., Babbs C. F., Voorhees W. D. III. Biochem. Pharmacol. 42:1991;499-506.
11. Kelner M. J., Bagnell R., Hale B., Alexander N. M. von Sonntag C. Oxygen Radicals in Biology and Medicine. 1988;895-898 Plenum, New York.
12. Dambrova M., Uhlén S., Welch C. J., Wikberg J. E. S. Eur. J. Biochem. 257:1998;178-184.
13. Veveris M., Dambrova M., Cirule H., Meirena D., Kalvinsh I., Wikberg Y. E. S. Br. J. Pharmacol. 128:1999;1089-1097.
14. Marquardt D. W. J. Soc. Ind. Appl. Math. 2:1963;431-441.
15. Druper N. R., Smith R. Applied Regression Analysis. 1966;Wiley, New York.
16. Frejaville C., Karoui H., Tuccio B., LeMoigne F., Culcasi M., Pietri S., Lauricella R., Tordo P. J. Med. Chem. 38:1995;258-265.
17. Tuccio B., Lauricella L., Frejaville C., Bouteiler J.-C. J. Chem. Soc., Perkin Trans. 2:1995;295-298.
18. Bray R. C. Boyer P. D. The Enzymes. 1976;299-419 Academic Press, New York.
19. Massey V., Komai H., Palmer G., Elion G. B. J. Biol. Chem. 245:1970;2837-2844.
20. Holland P. C., Clark M. G., Bloxham D. P., Lardy H. A. J. Biol. Chem. 248:1973;6050-6056.
21. Hille R., Massey V. Pharmacol. Ther. 14:1981;249-263.
22. Robins R. K., Revankar G. R., O'Brien D. E., Springer R. H., Novinson T., Miller J. P., Streeter D. G., Albert A., Senga K. J. Heterocycl. Chem. 22:1985;601-634.
23. Castelli P., Condemi A. M., Brambillasca C., Fundaro P., Botta M., Lemma M., Vanelli P., Santoli C., Gatti S., Riva E. J. Cardiovasc. Pharmacol. 25:1995;119-125.
24. Galili Y., Ben-Abraham R., Weinbroum A., Marmur S., Iaina A., Volman Y., Peer G., Szold O., Soffer D., Klausner J., Rabau M., Kluger Y. J. Trauma. 45:1998;222-226.
25. Nishino T. J. Biochem. 116:1994;1-6.